AMR of Streptococcus Pneumoniae Carriage Strains
NCT00198640 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-11-02
Summary
This study looks at the usage of human antibiotics for treatment of animals in Bangladesh.
Conditions
Interventions
- PROCEDURE
-
Antibiotic use
Sponsors & Collaborators
-
Johns Hopkins Bloomberg School of Public Health
lead OTHER
Principal Investigators
-
Mathuram Santosham, MD · Johns Hopkins Bloomberg School of Public Health
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- ECT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 0 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children
NCT04535661 ·Status: RECRUITING
-
Detection of Clindamycin Resistance Antibiotic Genes Among Staphylococcus Isolates by Using Real Time PCR
NCT04933019 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Resilience to Antibiotic-induced Obesogenic Microbiota: Discovering Mechanism of Microbiota Modulation
NCT06974994 ·Status: RECRUITING ·Phase: NA
-
Use of New Antibiotics in Sweden
NCT05048693 ·Status: COMPLETED
-
Comparison of Two Antibiotic Prophylactic Protocols in Preterm Premature Rupture of the Membranes
NCT02819570 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants
NCT00189384 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)
NCT03643952 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)
NCT01728363 ·Status: COMPLETED ·Phase: PHASE1
-
Ampicillin / Sulbactam vs. Ampicillin / Gentamicin for Treatment of Chorioamnionitis
NCT00879190 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Role of Guideline-adherent Perioperative Antibiotic Administration and the Risk of Surgical Site Infections After Non-cardiac Surgery.
NCT03982810 ·Status: WITHDRAWN
-
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
NCT02439359 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia
NCT00538694 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae
NCT00540072 ·Status: COMPLETED ·Phase: PHASE3
-
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
NCT04573504 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Colistin Based Antibiotic Therapy
NCT04764058 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends
NCT07013864 ·Status: COMPLETED
-
Bacterial Decolonization Within Dyads
NCT06541145 ·Status: RECRUITING ·Phase: NA
-
Intravenous and Oral Fosfomycin in Hospitalised Neonates With Clinical Sepsis
NCT03453177 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae
NCT02583373 ·Status: COMPLETED ·Phase: PHASE1
-
Surgical Site Infection After Episiotomy Repair Related to Routine Use of Antibiotic Prophylaxis in Low-Risk Population
NCT06154720 ·Status: COMPLETED
-
Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus
NCT00093067 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005)
NCT01728376 ·Status: COMPLETED ·Phase: PHASE4
-
Antibiotic Prophylaxis in Clean Surgery. Impact on Surgical Site Infection
NCT03595852 ·Status: COMPLETED ·Phase: NA
-
Early Antibiotic Therapy and Vaccination
NCT04109833 ·Status: UNKNOWN
-
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
NCT01019395 ·Status: COMPLETED ·Phase: PHASE1